Newsletter Signup | Community
Chemotherapy, biomarker testing and precision cancer medicines and immunotherapy are used to treat stage IIIB-IV NSCLC.
Surgery, radiation, and systemic therapies are all used to treat stage IIIA NSCLC.
Lobrena - a third generation ALK inhibitor drug with excellent CNS activity
Alcensa, Xalkori, and several other precision cancer medicines target ALK positive lung cancer and improve treatment.
Dana-Farber Cancer Institute’s Dr. Jackman M. D. discusses the latest advances in the management of lung cancer
Research suggests that the symptoms, type, and treatment of lung cancer is different in non-smokers than smokers.
HER 2 + Lung Cancer Treatment?
High incidence of ROS 1 false negative tests reported by U Colorado researchers.
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and work to overcome the…